ANTARES PHARMA ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of ATRS and Encourages Investors to Contact the Firm NEW YORK, April 13, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the officers or...

Aktana Delivers Intelligent Engagement Solution to Emerging and Mid-sized Life Sciences Companies SAN FRANCISCO, March 23, 2021 (GLOBE NEWSWIRE) -- Aktana, the global leader in intelligent customer engagement for the life sciences industry, announced the release of a dedicated configuration of...

Bragar Eagel & Squire, P.C. is Investigating Certain Officers and Directors of Antares Pharma, Inc. (ATRS) and Encourages ATRS Investors to Contact the Firm NEW YORK, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against certain officers and directors of Antares Pharma, Inc. (NASDAQ: ATRS). ...

EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Antares Pharma, Inc. – ATRS NEW YORK, Dec. 12, 2017 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Antares...

Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Antares Pharma, Inc. OKLAHOMA CITY, Oct. 25, 2017 (GLOBE NEWSWIRE) -- Federman & Sherwood announces that on October 23, 2017, a class action lawsuit was filed in the United States District Court for the District of...